| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
Artificial intelligence (AI) in the medical imaging industry is primarily responsible for improving the accuracy of diagnosis and patient outcomes. AI algorithms can analyze a large number of medical image data quickly and accurately. Help identify patterns and abnormalities that may be overlooked by the human eye. This consistent and accurate analysis helps to detect and treat diseases in the early stages such as cancer and cardiovascular disease. In addition, AI helps increase efficiency and improve patient satisfaction by reducing scanning time. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
The question asks for a key benefit of AI in radiology as noted in an article (which is not provided in the image). Based on general knowledge of AI applications in medicine, one significant role is to function as a supporting tool for radiologists, providing an additional layer of review or a "second opinion" to enhance accuracy and reduce errors.
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
The question asks what AI literacy refers to according to the article. Without the specific article text, the most logical and general definition of "literacy" in any subject is the understanding and knowledge of that subject. Therefore, "Understanding And Knowledge Of Al Technology" is the correct answer based on the common meaning of the term. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The Specified Factors Include Confidence In AI Systems (Trust In AI Systems), Integration Of AI Into Existing Workflows (Integration Of AI With Existing Workflows), System Understanding (System Understanding), And Technology Receptiveness (Technology Receptiveness). The Factor Of "The Color Of The AI Machines" (The Color Of The AI Machines) Is Not A Factor Listed As An Influence On The Acceptance Of AI Among Medical Personnel. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
According to the article, social influence plays an important role in the adoption of AI in health care. In particular, it affects the decision of medical personnel whether to use AI or not, which is an important factor in the adoption of new technologies in medical facilities. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
According to the article, social influence plays an important role in the adoption of AI in health care. In particular, it affects the decision of medical personnel whether to use AI or not, which is an important factor in the adoption of new technologies in medical facilities. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Based on general knowledge in the field of human-computer interaction and AI implementation in sensitive areas like medicine, the focus is often on usability, trust, and integration into existing workflows, which points towards a human-centred design approach. While high performance is important, it doesn't guarantee acceptance on its own. The specific article mentioned in the prompt is not available, but the most likely answer based on common academic consensus is human-centred design. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
This question is asked about the "system usage" category, which is generally related to the implementation of AI systems in a real environment. An important factor that affects use is the benefits (value proposition) and ease of integration with existing processes (integration with workflows). |
Technology Acceptance Theory (Technology Acceptance Model: TAM) and other acceptance frameworks often consider factors such as perception of usefulness (Perceived Usefulness) and perception of ease of use (Perceived Ease of Use), which are directly related to "value proposition" and "integration with workflows". These factors determine the intention to use and finally accept the system. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
The main reason why ethics affects the acceptance of AI is the concern that the AI system will be able to comply with basic medical ethics, such as the principle of non-maleficence and the principle of benefit (beneficence). If health professionals believe that AI is not consistent with these values, they are likely to refuse to use it. |
This concept is based on the theory of technology acceptance (Technology Acceptance Model - TAM) and 4 medical ethics (Four Pillars of Medical Ethics), which states that awareness of appropriateness and ethical conformity are important factors that influence attitudes and use of new technologies in the medical context. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
This option indicates that future studies should focus on integrating AI systems into real environments and user-oriented design. |
This principle is consistent with the idea that the success of adopting new technologies, especially in complex contexts such as medical or business, depends on how smoothly the user accepts and can be used with existing systems.
Many studies support that focusing solely on economic or speed factors is often insufficient to ensure long-term acceptance. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Parkinson's disease is caused by the loss of neurons that produce dopamine (dopamine neurons) in the brain. The use of stem cells from human embryonic (human embryonic stem cells) in treatment, the main goal is to bring back the lost neurons. These stem cells have the ability to develop into neurons that produce dopamine and transplant into the patient's brain to replace the dead cells. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
STEM-PD products have been tested for safety and efficacy in monkeys. By clinical trials in humans, stage 1/2a was conducted in patients with Parkinson's disease in Japan using this stem cell. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
3 months |
|
The duration of a preclinical safety study in rats mentioned in a specific article. Without access to the article referenced, it is impossible to determine the exact answer. The options provided are potential durations, but the correct choice depends entirely on the content of the source material. Therefore, the answer is based on the assumption that the provided option (a) 3 Months is the correct one as intended by the problem creator. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I |
|
The clinical trial project has many phases. Phase 1 (Phase I) has the main objective to assess the safety of a new treatment method in humans for the first time. For the STEM-PD project, which is a treatment using stem cells to replace lost dopamine neurons in patients with Parkinson's disease. In phase 1 to test safety is important. |
Phase 1 (Phase I): It is a preliminary study in a small group of participants (usually healthy volunteers or patients with specific indications) to check the safety, drug tolerance and pharmacokinetics (absorption, distribution, transformation and excretion of drugs).
STEM-PD Project: It is a stem cell transplant experiment that develops into dopamine neurons in the brain of Parkinson's patients. This experiment has been confirmed to be phase 1. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
STEM-PD products are manufactured under conditions that comply with GMP (Good Manufacturing Practice) standards, which are mandatory for the production of medical products or drugs to ensure the quality, safety and performance of the product. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
According to the principle of testing the safety of medical products or scientific experiments on laboratory animals, the confirmation that the product is safe usually comes from the observation that there are no harmful side effects (adverse effects) or tumor formation (tumor formation) occurring in experimental mice. Which shows that the product is non-toxic and does not cause cancer |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
The stem cells used in the STEM-PD experiment are dopamine-forming cells, which can develop into dopamine neurons that work when fully grown in the brain.
In the experiment of cell transplantation into the brain, the putamen area (putamen), which is the area where dopamine normally acts on the operation of the command system.
This study aims to develop the treatment of Parkinson's disease using safe and effective stem cells, with the aim of replacing neurons lost during the course of the disease. |
The main theory is cell transplant therapy (cell-replacement therapy). The transplanted cells are responsible for creating dopamine and connecting to the neural circuit in the brain to restore the function of the command system.
This principle relies on the ability of stem cells to divide and develop into specialized neurons. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
GIRK2 and ALDH1A1 |
|
Specific markers used in a research context, likely related to the differentiation of stem cells into Parkinson's disease (PD) related cell types. In relevant studies, the markers GIRK2 and ALDH1A1 are commonly used to assess the purity of dopaminergic neuron precursors or mature neurons derived from stem cells. These markers help identify specific subtypes of dopaminergic neurons, crucial for ensuring the quality and relevance of the cell batch for research or therapeutic purposes. |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are irrelevant to the process. |
|
Growth factors such as FGF8b (Fibroblast Growth Factor 8b) and SHH (Sonic Hedgehog) play a very important role in the development and patterning process of neurons during embryonic growth. In the context of STEM-PD cell production (which is thought to be related to the creation of dopamine neurons from stem cells), these stimulants are used to determine the direction for stem cells to change and develop into specific neurons as needed. Which is a process called cell patterning (cell patterning) |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|